Short description
InSyBio is a disruptor to Precision Medicine & Nutrition through effective personalization tests empowered with machine-learning.
Description
InSyBio is a biotechnology pioneer company (www.insybio.com) in personalized healthcare and nutrition which focuses on developing computational frameworks and tools for the analysis of complex life-science and biological data. The key objective of our analysis lies in discovering predictive integrated biosignatures (biomarkers of various categories) and models with increased prognostic and diagnostic aspects for personalized Healthcare and Nutrition Industries.
Our key products include:
-A SaaS platform, InSyBio Suite, for facilitating analysis of biomedical multi-omics data, reducing by 80% time and resources needs for such analysis and raising accuracy of predictive models by at least 10%.
-InSyBio Personalization Test which is a tailor-made product for each nutrition company allowing the personalization of nutrition, nutraceutical, vitamin and probiotic products.
Since June 2015 InSyBio participates in NBG Business Seeds program by National Bank of Greece and since 2021 InSyBio participates in the Loyal VC program.
For more information about our company contact us at info@insybio.com.
Last funding
Noaccess
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Narragansett, Rhode Island, United States, North America
Founded on
January 1, 2013
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$7890 - 12340
Sign in for full access
Investors
Cannot Access
Sign in for full access
Founders
Christos Alexakos, Konstantinos Theofilatos, Labros Digonis